Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group].
Martínez Alfaro EM, Cuadra F, Solera J, Maciá MA, Geijo P, Sánchez Martínez PA, Rodríguez Zapata M, Largo J, Sepúlveda MA, Rosa C, Sánchez L, Espinosa A, Mateos F, Blanch JJ. Martínez Alfaro EM, et al. Among authors: rodriguez zapata m. Med Clin (Barc). 2000 Jul 1;115(5):161-5. doi: 10.1016/s0025-7753(00)71496-5. Med Clin (Barc). 2000. PMID: 10996870 Clinical Trial. Spanish.
Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J, Rodríguez-Zapata M, Geijo P, Largo J, Paulino J, Sáez L, Martínez-Alfaro E, Sánchez L, Sepulveda MA, Ruiz-Ribó MD. Solera J, et al. Among authors: rodriguez zapata m. Antimicrob Agents Chemother. 1995 Sep;39(9):2061-7. doi: 10.1128/AAC.39.9.2061. Antimicrob Agents Chemother. 1995. PMID: 8540716 Free PMC article. Clinical Trial.
A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.
Solera J, Geijo P, Largo J, Rodriguez-Zapata M, Gijón J, Martinez-Alfaro E, Navarro E, Macia MA; Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Solera J, et al. Among authors: rodriguez zapata m. Clin Infect Dis. 2004 Dec 15;39(12):1776-82. doi: 10.1086/426024. Epub 2004 Nov 19. Clin Infect Dis. 2004. PMID: 15578399 Clinical Trial.
Multivariate model for predicting relapse in human brucellosis.
Solera J, Martínez-Alfaro E, Espinosa A, Castillejos ML, Geijo P, Rodríguez-Zapata M. Solera J, et al. Among authors: rodriguez zapata m. J Infect. 1998 Jan;36(1):85-92. doi: 10.1016/s0163-4453(98)93342-4. J Infect. 1998. PMID: 9515675
[Clinical trial comparing efficacy and safety of four highly active antiretroviral therapy (HAART) in antiretroviral-naive treatment with advanced HIV infection].
Geijo Martínez MP, Maciá Martínez MA, Solera Santos J, Barberá Farré JR, Rodríguez Zapata M, Marcos Sánchez F, Martínez Alfaro E, Cuadra García-Tenorio F, Sanz Moreno J, Moreno Mendaña JM, Beato Pérez JL, Sanz Sanz J; GECMEI. Geijo Martínez MP, et al. Among authors: rodriguez zapata m. Rev Clin Esp. 2006 Feb;206(2):67-76. doi: 10.1157/13085355. Rev Clin Esp. 2006. PMID: 16527165 Clinical Trial. Spanish.
[Immune response to microorganisms].
Manzano Espinosa L, Rodríguez Zapata M, Alvarez-Mon Soto M. Manzano Espinosa L, et al. Among authors: rodriguez zapata m. Med Clin (Barc). 1999 Oct 23;113(13):505-11. Med Clin (Barc). 1999. PMID: 10604177 Review. Spanish. No abstract available.
55 results